Saptagir Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 6 Year, 4 Days
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 27.12%
(FY 2023)
- Ebitda 48.82%
(FY 2023)
- Net Worth -5.59%
(FY 2023)
- Total Assets -2.64%
(FY 2023)
About Saptagir Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vijaya Jetty and Silpa Reganti serve as directors at the Company.
- CIN/LLPIN
U24290TG2019PTC130013
- Company No.
130013
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jan 2019
- Date of AGM
23 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Saptagir Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijaya Jetty  | Director | 24-Jan-2019 | Current |
Silpa Reganti  | Director | 24-Jan-2019 | Current |
Financial Performance of Saptagir Life Sciences.
Saptagir Life Sciences Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 27.12% increase in profit. The company's net worth dipped by a decrease of 5.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Saptagir Life Sciences?
In 2023, Saptagir Life Sciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Saptagir Camphor Private LimitedActive 36 years 11 monthsVijaya Jetty and Silpa Reganti are mutual person
Cetus Corporation Private LimitedActive 11 years 11 monthsVijaya Jetty and Silpa Reganti are mutual person
- Reganti Orphan's Educational Institute Of IndiaActive 21 years 11 months
Vijaya Jetty is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Saptagir Life Sciences?
Unlock and access historical data on people associated with Saptagir Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saptagir Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saptagir Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.